Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.

    Saji C, Higashi C, Niinaka Y, Yamada K, Noguchi K, Fujimuro M.

    Biochem Biophys Res Commun. 2011 Dec 2;415(4):573-8. Epub 2011 Oct 31.

    PMID:
    22074820
    [PubMed - indexed for MEDLINE]
    2.

    Involvement of Cot activity in the proliferation of ALCL lymphoma cells.

    Fernández M, Manso R, Bernáldez F, López P, Martín-Duce A, Alemany S.

    Biochem Biophys Res Commun. 2011 Aug 12;411(4):655-60. Epub 2011 Jun 29.

    PMID:
    21741362
    [PubMed - indexed for MEDLINE]
    3.

    The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein.

    Vogler M, Dickens D, Dyer MJ, Owen A, Pirmohamed M, Cohen GM.

    Biochem Biophys Res Commun. 2011 May 6;408(2):344-9. Epub 2011 Apr 13.

    PMID:
    21514278
    [PubMed - indexed for MEDLINE]
    4.

    Imaging and measuring the rituximab-induced changes of mechanical properties in B-lymphoma cells using atomic force microscopy.

    Li M, Liu L, Xi N, Wang Y, Dong Z, Tabata O, Xiao X, Zhang W.

    Biochem Biophys Res Commun. 2011 Jan 14;404(2):689-94. Epub 2010 Dec 13.

    PMID:
    21156157
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk